DRUG DEVELOPMENT DECONSTRUCTOR MANIFESTO: : “Tell me how you read and I'll tell you who you are.” ― Martin Heidegger
Thursday, December 12, 2013
Tuesday, December 10, 2013
Monday, December 9, 2013
Sunday, December 8, 2013
Saturday, December 7, 2013
Bent penis? 5%of U.S. men are affected! Not a problem anymore!
Post-modern Health problems - not a joke!!!
WASHINGTON (AP) -- The Food and Drug Administration on Friday approved the first drug to treat an unusual condition that causes painful, curved erections in men.
FDA says the injectable drug is the first non-surgical treatment for the disease.
Drugmaker Auxilium Pharmaceuticals estimates 5 percent of U.S. men are affected. - It sounds like an epidemic!
Xiaflex was previously approved in 2010 to treat a hand disease that interferes with patients' ability to straighten their fingers. The FDA said in its release that Xiaflex is believed to treat Peyronie's disease by breaking down collagen plaque that builds up in the penis and causes the deformity.
The FDA said it is limiting distribution of the drug to certified physicians and health care centers due to serious potential side effects, including injury of the penis. Health care professionals must enroll and complete a training program before prescribing the drug.
The FDA approved Xiaflex for its new use based on two studies of 832 men with Peyronie's disease. Patients received up to eight injections of the drug and were then followed for a year to see if their condition improved. Patients who received the drug reported significantly fewer problems than those who received a dummy injection.
The drug was developed by BioSpecifics Technologies Corp. of Lynbrook, N.Y., and submitted to the FDA by Chesterbrook, Pa.-based Auxilium Pharmaceuticals Inc.
Shares of Auxilium rose $1.80, or 9.3 percent, to $21.13 in afternoon trading.
Subscribe to:
Posts (Atom)